Fujitsu Of Japan Opens Biomedical Research Center In Singapore
This article was originally published in PharmAsia News
Executive SummaryJapan's Fujitsu says it has begun work at its new biomedical research center in Singapore on using antibodies to detect diseases, including cancer
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.